Facial paralysis is not effective with creams alone. Facial paralysis should be treated with a regular treatment program. For central facial paralysis such as cerebral infarction, reteplase should be given in the hyperacute phase. In cerebral hemorrhage, mannitol is given to reduce edema. Treatment for peripheral facial palsy includes antiviral therapy, such as acyclovir; anti-inflammatory therapy, such as dexamethasone; and nutritive neurologic therapy, such as vitamin B12.
1. Central facial paralysis: common causes include cerebral infarction or cerebral hemorrhage.
Thrombolytic therapy such as reteplase and alteplase should be given in the hyperacute phase of cerebral infarction. Aspirin and clopidogrel anti-platelet aggregation; simvastatin and pitavastatin to stabilize plaque; edaravone brain protection, etc. should be given beyond the window period.
At the onset of cerebral hemorrhage, drugs such as sodium nitroprusside and uradil are given to adjust blood pressure. Mannitol, furosemide, etc. reduce edema and lower intracranial pressure; if there is a surgical indication, surgical treatment will be carried out under the guidance of doctors.
When the condition of cerebrovascular disease is stable, local physical therapy can be given, including acupuncture, microwave therapy and red light therapy.
2. Peripheral facial paralysis
The most common cause of peripheral facial paralysis is facial neuritis. Antiviral treatment with ganciclovir or acyclovir, anti-inflammatory drugs such as dexamethasone and methylprednisolone can be given to reduce facial nerve edema, and drugs such as vitamin B12, methylcobalamin and adenosylcobalamin can be given to nourish the nerves.
It is recommended that the patient under the guidance of the doctor to timely choose a reasonable treatment program, to avoid the sequelae.